Evaluation of the Efficacy of Vacquinol-1 In Glioblastoma Multiforme
School Name
South Carolina Governor's School for Science & Mathematics
Grade Level
12th Grade
Presentation Topic
Cell and Molecular Biology
Presentation Type
Mentored
Abstract
Glioblastoma Multiforme is a malignant and aggressive tumor that accounts for over 80% of brain tumors. Only half of the patients diagnosed survive even after chemotherapy and radiotherapy. In efforts to increase these survival rates, new treatments are being analyzed. One of these new treatments include Vacquinol-1, a drug used to kill GBM cells through methuosis. Methuosis is a form of cell death that is non-apoptotic, differing from the apoptotic forms of cell death used by chemotherapy and radiotherapy. Methuosis exclusively kills the cancerous cells, through a process called catastrophic vacuolization, while leaving the healthy cells alive.
Recommended Citation
Merchant, Omika, "Evaluation of the Efficacy of Vacquinol-1 In Glioblastoma Multiforme" (2020). South Carolina Junior Academy of Science. 81.
https://scholarexchange.furman.edu/scjas/2020/all/81
Location
Furman Hall 107
Start Date
3-28-2020 11:45 AM
Presentation Format
Oral Only
Group Project
No
Evaluation of the Efficacy of Vacquinol-1 In Glioblastoma Multiforme
Furman Hall 107
Glioblastoma Multiforme is a malignant and aggressive tumor that accounts for over 80% of brain tumors. Only half of the patients diagnosed survive even after chemotherapy and radiotherapy. In efforts to increase these survival rates, new treatments are being analyzed. One of these new treatments include Vacquinol-1, a drug used to kill GBM cells through methuosis. Methuosis is a form of cell death that is non-apoptotic, differing from the apoptotic forms of cell death used by chemotherapy and radiotherapy. Methuosis exclusively kills the cancerous cells, through a process called catastrophic vacuolization, while leaving the healthy cells alive.
